- Home
- ENTX vs STKS Comparison
ENTX vs STKS Comparison
Compare ENTX & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENTX | STKS |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 74.3M |
| IPO Year | 2015 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ENTX | STKS |
|---|---|---|
| Price | $1.50 | $1.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $4.38 |
| AVG Volume (30 Days) | ★ 147.2K | 14.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | $181,000.00 | ★ $673,344,000.00 |
| Revenue This Year | N/A | $23.94 |
| Revenue Next Year | N/A | $5.93 |
| P/E Ratio | $6.97 | ★ N/A |
| Revenue Growth | N/A | ★ 102.35 |
| 52 Week Low | $1.00 | $1.70 |
| 52 Week High | $3.22 | $5.19 |
Technical Indicators
Market Signals| Indicator | ENTX | STKS |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 42.25 |
| Support Level | $1.45 | $1.89 |
| Resistance Level | $1.65 | $2.65 |
| Average True Range (ATR) | 0.13 | 0.12 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 66.67 | 7.69 |
Price Performance
Historical ComparisonAbout ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.